HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M A Taubman Selected Research

Glucosyltransferases

2/2007Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding.
8/2003Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
7/2001Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries.
5/2000Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M A Taubman Research Topics

Disease

6Bone Resorption
06/2007 - 02/2000
6Dental Caries (Decay, Dental)
02/2007 - 05/2000
5Periodontal Diseases (Periodontal Disease)
06/2009 - 08/2000
4Infections
08/2008 - 05/2000
2Periodontitis
06/2017 - 07/2000
2Alveolar Bone Loss
06/2017 - 06/2007
2Inflammation (Inflammations)
11/2006 - 06/2005
1Communicable Diseases (Infectious Diseases)
05/2014
1Oral Candidiasis (Thrush)
05/2014
1Streptococcal Infections (Streptococcal Infection)
08/2008
1Respiratory Tract Diseases (Respiratory Tract Disease)
08/2003
1Cholera
08/2001
1Chronic Periodontitis
08/2000
1Gingivitis
07/2000

Drug/Important Bio-Agent (IBA)

6Peptides (Polypeptides)IBA
02/2007 - 05/2000
4RANK LigandIBA
06/2017 - 05/2007
4GlucosyltransferasesIBA
02/2007 - 05/2000
3Immunoglobulin A (IgA)IBA
08/2008 - 08/2001
3VaccinesIBA
02/2007 - 08/2001
3CytokinesIBA
06/2005 - 08/2000
3Immunoglobulin G (IgG)IBA
08/2001 - 02/2000
2Proteins (Proteins, Gene)FDA Link
06/2017 - 08/2008
2Messenger RNA (mRNA)IBA
06/2017 - 08/2000
1Monoclonal AntibodiesIBA
06/2017
1Tartrate-Resistant Acid PhosphataseIBA
06/2017
1LipoxinsIBA
05/2014
1Interleukin-17 (Interleukin 17)IBA
05/2014
1OsteoprotegerinIBA
06/2007
1NF-kappa B (NF-kB)IBA
05/2007
1LigandsIBA
05/2007
1CathelicidinsIBA
11/2006
1beta-DefensinsIBA
11/2006
1AntigensIBA
04/2006
1Potassium Channels (Potassium Channel)IBA
06/2005
1Potassium Channel Blockers (Blockers, Potassium Channel)IBA
06/2005
1glucan-binding proteinsIBA
02/2005
1poly(lactide) (polylactic acid)IBA
02/2005
1salicylhydroxamic acid (SHAM)IBA
08/2003
1E coli heat-labile enterotoxinIBA
08/2001
1Interleukin-1 (Interleukin 1)IBA
01/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2001
1Interleukin-2 (IL2)IBA
08/2000
1Interleukin-5 (Interleukin 5)IBA
08/2000
1AntibodiesIBA
07/2000
1EnzymesIBA
05/2000
1GlucansIBA
05/2000
1Membrane Proteins (Integral Membrane Proteins)IBA
02/2000

Therapy/Procedure

2Therapeutics
05/2014 - 06/2005
1Ligation
06/2017
1Mucosal Administration
08/2001